Attomarker constantly innovates and delivers

Gold Standard
Rapid Diagnostics

at the point-of-care

Suffering from Long Covid?

You can book an Attomarker Multi-Variant Antibody Immunity Spectrum (AMVAIS) Test to explore treatment options with partner clinics worldwide.*

Attomarker believes that new challenges to our health require innovative answers inspired by rigorous science.

Listen to the CEO and Founder of Attomarker, Professor Shaw, discussing the AMVAIS test on Dr Binita Kane’s Fireside Chat

For thousands of years clinicians have had to make diagnoses based on symptoms alone.  More recently we have had blood tests, but the results often arrive too late or are too uni-dimensional.

Attomarker offers rapid personalised multi-dimensional diagnosis that enables earlier treatment designed to meet your unique, individual healthcare needs.

High quality diagnosis, which can be mapped against symptoms using AI, will reach beyond the laboratory and be accessible to everyone, in clinics, pharmacies and at home.



*Clinican-led named-patient research test


7 reasons